{"id":"NCT00833794","sponsor":"Labopharm Inc.","briefTitle":"A Two-Arm Study Comparing the Analgesic Efficacy and Safety of Tramadol HCl Once-a-Day Versus Placebo for the Treatment of Pain Due to Osteoarthritis","officialTitle":null,"status":"COMPLETED","phase":"PHASE3","dates":{"start":"2004-10","primaryCompletion":"2006-01","completion":"2006-01","firstPosted":"2009-02-02","resultsPosted":"2009-08-10","lastUpdate":"2012-04-30"},"enrollment":1028,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Pain","Osteoarthritis"],"interventions":[{"type":"DRUG","name":"Tramadol Once a day","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"1 Tramadol Once A Day","type":"EXPERIMENTAL"},{"label":"2 Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study is to compare the analgesic efficacy, safety and clinical benefit of Tramadol OAD tablets versus Placebo.","primaryOutcome":{"measure":"Pain Intensity Score as Measured by the 11-point Pain Intensity-Numerical Rating Scale Score at the End of the Study (Week 12 or Time of Discontinuation)","timeFrame":"12 weeks","effectByArm":[{"arm":"1 Tramadol Once A Day","deltaMin":4.3,"sd":2.5},{"arm":"2 Placebo","deltaMin":4.8,"sd":2.4}],"pValues":[]},"eligibility":{"minAge":"40 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":3},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":["17583466"],"seeAlso":["http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?id=9048"]},"adverseEventsSummary":{"seriousAny":{"events":9},"commonTop":["Nausea","Constipation","Somnolence","Dizziness"]}}